Aims & Scope
RETINA® focuses exclusively on the growing specialty of vitreoretinal disorders.
The Journal provides current information on diagnostic and therapeutic techniques.
Its highly specialized and informative, peer-reviewed articles are easily applicable to clinical practice.
In addition to regular reports from clinical and basic science investigators, RETINA® publishes special features including periodic review articles on pertinent topics, special articles dealing with surgical and other therapeutic techniques, and abstract cards.
Issues are abundantly illustrated in vivid full color.
Published 12 times per year, RETINA® is truly a “must have” publication for anyone connected to this field.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 2.1 |
| 2024 | 2.30 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 1.018 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q1 |
h-index
| Year | Value |
|---|---|
| 2024 | 149 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 4686 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 2395 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
IMAGE ARTIFACTS IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY
Citation: 872
Authors: Richard F., James G., Nadia K.
-
ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY
Citation: 762
Authors: YUTAKA, TAKAMITSU, RON, RICHARD F.
-
DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Citation: 644
Authors: NAPOLEONE, LISA, NAVEED, HENRY, ROBERT
-
RETINAL ANGIOMATOUS PROLIFERATION IN AGE-RELATED MACULAR DEGENERATION
Citation: 566
Authors: LAWRENCE A., SILVANA, TOMOHIRO, CYNTHIA, HANNA, JASON, K. BAILEY, JOHN, DENNIS, NATALIE
-
ANATOMICAL CORRELATES TO THE BANDS SEEN IN THE OUTER RETINA BY OPTICAL COHERENCE TOMOGRAPHY
Citation: 540
Authors: Richard F, Christine A
-
EVEREST STUDY
Citation: 502
Authors: Adrian, Won Ki, Lee-Jen, Shih-Jen, Yehia, Hakyoung, Timothy Y., Stefan, Paisan, Erika, Annemarie, Tock H.
-
IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)
Citation: 492
Authors: LAWRENCE A., JOHN, RICHARD F., BARRY
-
INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY
Citation: 464
Authors: RICHARD F., LAWRENCE A., JASON S., JOHN, DENNIS A.